NCT04131686View on ClinicalTrials.gov

NAC Inhalation in the Treatment Of Symptomatic acuTe rhinosinUSitis

CompletedOBSERVATIONAL
Enrollment

294

Participants

Timeline

Start Date

September 30, 2019

Primary Completion Date

September 17, 2021

Study Completion Date

September 17, 2021

Conditions
Acute RhinosinusitisRecurrent Acute RhinosinusitisChronic Rhinosinusitis
Trial Locations (1)

Unknown

The Catholic University of Korea, Yeouido ST. Mary's Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Boryung Pharmaceutical Co., Ltd

INDUSTRY

NCT04131686 - NAC Inhalation in the Treatment Of Symptomatic acuTe rhinosinUSitis | Biotech Hunter | Biotech Hunter